Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets
- PMID: 26166604
- DOI: 10.2174/1381612821666150710150445
Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets
Abstract
Despite recent advances in therapy, heart failure remains a major cause of mortality and morbidity and is a growing healthcare burden worldwide. Alterations in myocardial energy substrate metabolism are a hallmark of heart failure, and are associated with an energy deficit in the failing heart. Previous studies have shown that a metabolic shift from mitochondrial oxidative metabolism to glycolysis, as well as an uncoupling between glycolysis and glucose oxidation, plays a crucial role in the development of cardiac inefficiency and functional impairment in heart failure. Therefore, optimizing energy substrate utilization, particularly by increasing mitochondrial glucose oxidation, can be a potentially promising approach to decrease the severity of heart failure by improving mechanical cardiac efficiency. One approach to stimulating myocardial glucose oxidation is to inhibit fatty acid oxidation. This review will overview the physiological regulation of both myocardial fatty acid and glucose oxidation in the heart, and will discuss what alterations in myocardial energy substrate metabolism occur in the failing heart. Furthermore, lysine acetylation has been recently identified as a novel post-translational pathway by which mitochondrial enzymes involved in all aspects of cardiac energy metabolism can be regulated. Thus, we will also discuss the effect of acetylation of metabolic enzymes on myocardial energy substrate preference in the settings of heart failure. Finally, we will focus on pharmacological interventions that target enzymes involved in fatty acid uptake, fatty acid oxidation, transcriptional regulation of fatty acid oxidation, and glucose oxidation to treat heart failure.
Similar articles
-
Metabolic Modulators in Heart Disease: Past, Present, and Future.Can J Cardiol. 2017 Jul;33(7):838-849. doi: 10.1016/j.cjca.2016.12.013. Epub 2016 Dec 21. Can J Cardiol. 2017. PMID: 28279520 Review.
-
Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.Biochim Biophys Acta. 2011 Jul;1813(7):1333-50. doi: 10.1016/j.bbamcr.2011.01.015. Epub 2011 Jan 20. Biochim Biophys Acta. 2011. PMID: 21256164 Review.
-
Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure.Biochim Biophys Acta. 2016 Dec;1862(12):2211-2220. doi: 10.1016/j.bbadis.2016.07.020. Epub 2016 Jul 29. Biochim Biophys Acta. 2016. PMID: 27479696 Review.
-
Cardiac Energy Metabolism in Heart Failure.Circ Res. 2021 May 14;128(10):1487-1513. doi: 10.1161/CIRCRESAHA.121.318241. Epub 2021 May 13. Circ Res. 2021. PMID: 33983836 Free PMC article. Review.
-
Acetylation and succinylation contribute to maturational alterations in energy metabolism in the newborn heart.Am J Physiol Heart Circ Physiol. 2016 Aug 1;311(2):H347-63. doi: 10.1152/ajpheart.00900.2015. Epub 2016 Jun 3. Am J Physiol Heart Circ Physiol. 2016. PMID: 27261364
Cited by
-
Use of a Systematic Pharmacological Methodology to Explore the Mechanism of Shengmai Powder in Treating Diabetic Cardiomyopathy.Med Sci Monit. 2020 Feb 5;26:e919029. doi: 10.12659/MSM.919029. Med Sci Monit. 2020. PMID: 32023237 Free PMC article.
-
Successful metabolic adaptations leading to the prevention of high fat diet-induced murine cardiac remodeling.Cardiovasc Diabetol. 2015 Sep 25;14:127. doi: 10.1186/s12933-015-0286-0. Cardiovasc Diabetol. 2015. PMID: 26408147 Free PMC article.
-
Expert consensus document: Mitochondrial function as a therapeutic target in heart failure.Nat Rev Cardiol. 2017 Apr;14(4):238-250. doi: 10.1038/nrcardio.2016.203. Epub 2016 Dec 22. Nat Rev Cardiol. 2017. PMID: 28004807 Free PMC article. Review.
-
Metabolic Syndrome and Biotherapeutic Activity of Dairy (Cow and Buffalo) Milk Proteins and Peptides: Fast Food-Induced Obesity Perspective-A Narrative Review.Biomolecules. 2024 Apr 14;14(4):478. doi: 10.3390/biom14040478. Biomolecules. 2024. PMID: 38672494 Free PMC article. Review.
-
Metabolomics coupled with integrated approaches reveal the therapeutic effects of higenamine combined with [6]-gingerol on doxorubicin-induced chronic heart failure in rats.Chin Med. 2020 Nov 17;15(1):120. doi: 10.1186/s13020-020-00403-0. Chin Med. 2020. PMID: 33292391 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical